M&A Deal Summary

Bausch Health Acquires Medicis Pharmaceutical

On December 11, 2012, Bausch Health acquired life science company Medicis Pharmaceutical for 2.6B USD

Acquisition Highlights
  • This is Bausch Health’s 15th transaction in the Life Science sector.
  • This is Bausch Health’s 3rd largest (disclosed) transaction.
  • This is Bausch Health’s 10th transaction in the United States.
  • This is Bausch Health’s 1st transaction in Arizona.

M&A Deal Summary
Date 2012-12-11
Target Medicis Pharmaceutical
Sector Life Science
Buyer(s) Bausch Health
Deal Type Add-on Acquisition
Deal Value 2.6B USD
Advisor(s) Deutsche Bank Corporate & Investment Banking
Roberts Mitani (Financial)
Weil Gotshal & Manges
Latham & Watkins (Legal)

Target

Medicis Pharmaceutical

Scottsdale, Arizona, United States
Medicis Pharmaceutical Corporation is a pharmaceutical company in the United States focusing primarily on the treatment of dermatological and aesthetic conditions.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bausch Health

Laval, Quebec, Canada
Category Company
Sector Life Science
Employees20,270
Revenue 8.8B USD (2023)
DESCRIPTION

Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.

DEAL STATS #
Overall 21 of 35
Sector (Life Science) 15 of 21
Type (Add-on Acquisition) 14 of 25
State (Arizona) 1 of 1
Country (United States) 10 of 22
Year (2012) 6 of 6
Size (of disclosed) 3 of 27
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-06-15 OraPharma

Horsham, Pennsylvania, United States

OraPharma, Inc. is a pharmaceutical company that discovers, develops and commercializes therapeutics for the treatment of periodontal disease at various phases of progression.

Buy $312M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-02-01 Natur Produkt

Saint Petersburg, Russia

Natur Produkt provides (OTC) drugs segment in several categories marketed under the umbrella brand, Natur Produkt. Key brands include AntiGrippin, a leading cough and cold remedy, Anti Angin, Sage and Eucaplyptus MA.

Buy $163M
Mergr

Product

Company

Legal